This is a Phase 1/2b multiple dose, parallel group, double blind, vehicle-controlled study of the safety and efficacy of ARQ-252 cream in subjects with chronic hand eczema
This study will assess the safety and efficacy of ARQ-252 cream in subjects with chronic hand eczema